GPI and breast cancer: Furthermore, glycolytic phosphoglucose isomerase (PGI)/autocrine motility factor (AMF) is associated with EMT in breast cancer cells and the expression of mesenchymal markers zinc finger E-box-binding homeobox 1 (ZEB1) and ZEB2 (41).